Pfizer could have data on how well its Covid-19 vaccine works in kids under age 5 by the end of the year, according to CEO Albert Bourla. "We have a study in children 6 months to 2 years and then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results